跳至主要内容
临床试验/CTRI/2022/07/044160
CTRI/2022/07/044160尚未招募2/3 期

RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFICACY OF ARAGWADHADI TAILA IN COMPARISON WITH BETADINE LIQUID IN THE MANAGEMENT OF DUSHTA VRANA.

DR AMRUTA ARVIND NARKAR1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年7月25日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1)Dushta vrana (infected wound) has been explained as a stage of vrana in many classical texts. Also, Dushta vrana (infected wound) has been mentioned as a type of vrana (wound).

研究概览

简要总结

aim of the study will be to give ayurvedic treatment to diseased patient to improve his / her condition and we can give his / her cheap, safe side effect free management. The trial will be conducted on 60 patients for follow up of 0,5,10,15 days and doses of drug as per required once a day for 15 days with 4 follow up (0,5,10,15 days )

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
19.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients having sign and symptoms of Dushta Vrana i.e.infected wound. 2.Dushta Vrana size up to 5×5cms (LxB) 3.Patients of either sex will be selected. 4.The patients of age group 19.

排除标准

  • 1.Anaemic patient Hb < 10 gm 2.Malnourished patient (as per age, height and weight proportion) 3.Bleeding disorders (increased B.T and C.T) 4.Patient with septicemia 5.The patients suffering from systemic disease such as AIDS, Tuberculosis, Uncontrolled Diabetes mellitus, Hepatitis-B, Malignancy, Vericose ulcer, Deep vein thrombosis, Neurogenic ulcer, Leukemia, etc.
  • 6.Any congenital diseases or abnormalities.

结局指标

主要结局

1)Dushta vrana (infected wound) has been explained as a stage of vrana in many classical texts. Also, Dushta vrana (infected wound) has been mentioned as a type of vrana (wound).

时间窗: 15 Days of study (0,5,10,15 days)

2)To evaluate the eshtablish safer, cost-effective aragwadhadi taila in the management of dushta vrana (infected wound)

时间窗: 15 Days of study (0,5,10,15 days)

次要结局

  • Aragwadhadi Taila is effective management of dushta vrana(15 days of study (0,5,10,15))

研究者

发起方
DR AMRUTA ARVIND NARKAR
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验